Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NYSE: RVTY

Revvity, Inc.

Healthcare | Medical - Diagnostics & Research

Market prices for RVTY are shown to signed-in users (sign in). This public page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$2.09

Revvity, Inc. (NYSE: RVTY) is a diagnostics and research company. Figures from SEC EDGAR; updated 2026-10-20 03:06 UTC.

What Revvity, Inc. does

Revvity is a health science company headquartered in Waltham, Massachusetts that provides technologies, expertise and services supporting scientific research and medical applications from discovery through diagnosis and treatment. The company operates in two business segments—Life Sciences and Diagnostics—and serves pharmaceutical, biotech, contract research, academic and government institutions globally.

Summarized from Revvity, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation
EPS (TTM)$2.09
Return on equity3.33%
Debt/equity0.36

Revenue, margins & earnings

FY2021 Net income: $943MFY2021 Taxes & interest: $315MFY2021 Operating costs: $2.57B$3.83BFY2021FY2022 Net income: $569MFY2022 Taxes & interest: $174MFY2022 Operating costs: $2.57B$3.31BFY2022FY2023 Revenue: $2.75B — margin split not shown (non-operating gains)$2.75BFY2023FY2024 Net income: $270MFY2024 Taxes & interest: $76MFY2024 Operating costs: $2.41B$2.76BFY2024FY2025 Net income: $241MFY2025 Taxes & interest: $115MFY2025 Operating costs: $2.50B$2.86BFY2025
  • Net income
  • Taxes & interest
  • Operating costs
Annual revenue; bands show net, operating margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-10-02
  • 2026-10-02VP and CAOSale-84$13.1K
  • 2026-09-23Please See RemarksSale-1,631$235.7K
  • 2026-09-18Please See RemarksSale-7,330$1.03M
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Revvity, Inc. do?

Revvity is a health science company headquartered in Waltham, Massachusetts that provides technologies, expertise and services supporting scientific research and medical applications from discovery through diagnosis and treatment.

When did RVTY last file with the SEC?

Revvity, Inc.'s most recent SEC filing on record is a SCHEDULE 13G/A filed 2026-10-07. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 03:06 UTC. This page is also available as JSON at /api/data?ticker=RVTY and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for RVTY and 5,000+ tickers.

Create a free account — keep RVTY
For your agent
GET /api/data?ticker=RVTY

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt